We are live on ! Find out more
LUCD icon

Lucid Diagnostics
LUCD

32 hedge funds and large institutions have $9.09M invested in Lucid Diagnostics in 2022 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 7 increasing their positions, 12 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

1.64% less ownership

Funds ownership: 8.99% → 7.35% (-1.6%)

9% less funds holding

Funds holding: 35 → 32 (-3)

30% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 10

42% less repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 12

49% less capital invested

Capital invested by funds: $17.8M → $9.09M (-$8.67M)

Holders
32
Holders Change
-3
Holders Change %
-8.57%
% of All Funds
0.5%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
7
Increased
7
Reduced
12
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BCM
Bridgeway Capital Management
Texas
+$676K
2
Vanguard Group
Vanguard Group
Pennsylvania
+$233K
3
GWM
Geneos Wealth Management
Colorado
+$228K
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$146K
5
Verition Fund Management
Verition Fund Management
Connecticut
+$132K

Top Sellers

Rank Fund Capital Flow
1
LM
Luminus Management
Texas
-$1.84M
2
CC
Covalis Capital
United Kingdom
-$722K
3
NCM
Nantahala Capital Management
Connecticut
-$437K
4
Millennium Management
Millennium Management
New York
-$351K
5
CF
Cantor Fitzgerald
New York
-$305K
Name Holding Trade Value Shares
Change 		Change in
Stake
Royal Bank of Canada
26
Royal Bank of Canada
Ontario, Canada
$3K -$2.79K -764 -46%
AB
27
Amalgamated Bank
New York
$3K +$2.76K +756 New
AF
28
Amalgamated Financial
New York
$3K +$2.76K +756 New
Citigroup
29
Citigroup
New York
$2K -$6.04K -1,653 -70%
Legal & General Group
30
Legal & General Group
United Kingdom
$2K – – –
Barclays
31
Barclays
United Kingdom
$2K +$3K +822 New
AIP
32
Ameritas Investment Partners
Nebraska
$1K – – –
CC
33
Covalis Capital
United Kingdom
– -$722K -134,532 Closed
Millennium Management
34
Millennium Management
New York
– -$351K -65,315 Closed
Goldman Sachs
35
Goldman Sachs
New York
– -$132K -24,540 Closed
Renaissance Technologies
36
Renaissance Technologies
New York
– -$107K -20,000 Closed
Invesco
37
Invesco
Georgia
– -$93K -17,331 Closed
Two Sigma Investments
38
Two Sigma Investments
New York
– -$86K -15,964 Closed
Susquehanna International Group
39
Susquehanna International Group
Pennsylvania
– -$71K -13,255 Closed
VF
40
Virtu Financial
New York
– -$61K -11,359 Closed
KC
41
KCL Capital
New York
– -$54K -10,000 Closed
Carson Wealth (CWM LLC)
42
Carson Wealth (CWM LLC)
Nebraska
– -$1K -200 Closed
1
2

LUCD Hedge Fund Activity: Q1 2022 in Review

32 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Lucid Diagnostics (LUCD) for Q1 2022, worth a combined $9.09M — down 49% from $17.8M a quarter earlier.

Sellers outnumbered buyers: 10 funds closed out of LUCD and 7 opened new positions — a net loss of 3 holders — while 12 trimmed existing stakes and 7 added.

The largest buyer was Bridgeway Capital Management, opening a new position worth an estimated $676K. The largest seller was Luminus Management, cutting an estimated $1.84M.

  • 32 institutional investors held Lucid Diagnostics (LUCD) as of Q1 2022, down from 35 in Q4 2021.
  • Funds reported $9.09M of Lucid Diagnostics stock for Q1 2022, down 49% quarter-over-quarter.
  • 7 funds opened new Lucid Diagnostics positions in Q1 2022 and 10 closed out, a net change of -3 holders.
  • The largest Lucid Diagnostics buyer in Q1 2022 was Bridgeway Capital Management, an estimated $676K added.
  • The largest Lucid Diagnostics seller in Q1 2022 was Luminus Management, an estimated $1.84M sold.

Based on aggregated 13F filings for Q1 2022.